AstraZeneca
AZN
#45
Rank
HK$2.294 T
Marketcap
HK$1,480
Share price
0.27%
Change (1 day)
24.39%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): HK$41.71

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$41.91. In 2024 the company made an earnings per share (EPS) of HK$35.57 an increase over its 2023 EPS that were of HK$30.08.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$41.7117.28%
2024HK$35.5718.23%
2023HK$30.0881.13%
2022HK$16.61631.03%
2021HK$2.27-88.11%
2020HK$19.11136.89%
2019HK$8.07-39.41%
2018HK$13.32-28.27%
2017HK$18.57-14.37%
2016HK$21.6824.11%
2015HK$17.47127.55%
2014HK$7.68-51.96%
2013HK$15.98-58.95%
2012HK$38.93-32.2%
2011HK$57.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.25 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.66 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.37-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.33 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.18-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$86.09 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.24 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.27-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.52-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK